Nora Ness

812 total citations
16 papers, 634 citations indexed

About

Nora Ness is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Molecular Biology. According to data from OpenAlex, Nora Ness has authored 16 papers receiving a total of 634 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 8 papers in Cancer Research and 6 papers in Molecular Biology. Recurrent topics in Nora Ness's work include Prostate Cancer Treatment and Research (8 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (5 papers). Nora Ness is often cited by papers focused on Prostate Cancer Treatment and Research (8 papers), Cancer-related molecular mechanisms research (5 papers) and MicroRNA in disease regulation (5 papers). Nora Ness collaborates with scholars based in Norway, United Kingdom and Italy. Nora Ness's co-authors include Roy M. Bremnes, Elin Richardsen, Tom Dønnem, Sigve Andersen, Lill‐Tove Busund, Yngve Nordby, Samer Al‐Saad, Mehrdad Rakaee, Andrej Valkov and Erna‐Elise Paulsen and has published in prestigious journals such as PLoS ONE, Scientific Reports and American Journal Of Pathology.

In The Last Decade

Nora Ness

16 papers receiving 629 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nora Ness Norway 15 294 256 243 242 134 16 634
Yngve Nordby Norway 15 255 0.9× 191 0.7× 236 1.0× 233 1.0× 109 0.8× 15 562
Allen Saliganan United States 12 202 0.7× 275 1.1× 181 0.7× 263 1.1× 74 0.6× 14 605
Sofia Halin Bergström Sweden 15 251 0.9× 181 0.7× 171 0.7× 342 1.4× 247 1.8× 29 735
Karama Asleh Canada 12 177 0.6× 314 1.2× 217 0.9× 275 1.1× 121 0.9× 25 669
Adam R. Wolfe United States 11 150 0.5× 312 1.2× 238 1.0× 264 1.1× 125 0.9× 33 639
Guoping Ren China 15 314 1.1× 181 0.7× 217 0.9× 250 1.0× 54 0.4× 40 654
Anna Wurtz United States 11 296 1.0× 278 1.1× 127 0.5× 266 1.1× 53 0.4× 19 595
Zhi-Ming Shao China 7 222 0.8× 360 1.4× 365 1.5× 464 1.9× 151 1.1× 10 862
Erin L. Maresh United States 13 241 0.8× 277 1.1× 118 0.5× 341 1.4× 64 0.5× 15 647
Anne Offermann Germany 17 322 1.1× 308 1.2× 166 0.7× 366 1.5× 149 1.1× 55 820

Countries citing papers authored by Nora Ness

Since Specialization
Citations

This map shows the geographic impact of Nora Ness's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nora Ness with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nora Ness more than expected).

Fields of papers citing papers by Nora Ness

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nora Ness. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nora Ness. The network helps show where Nora Ness may publish in the future.

Co-authorship network of co-authors of Nora Ness

This figure shows the co-authorship network connecting the top 25 collaborators of Nora Ness. A scholar is included among the top collaborators of Nora Ness based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nora Ness. Nora Ness is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Richardsen, Elin, Sigve Andersen, Samer Al‐Saad, et al.. (2019). Low Expression of miR-424-3p is Highly Correlated with Clinical Failure in Prostate Cancer. Scientific Reports. 9(1). 10662–10662. 28 indexed citations
2.
Richardsen, Elin, Sigve Andersen, Mehrdad Rakaee, et al.. (2019). MicroRNA 141 is associated to outcome and aggressive tumor characteristics in prostate cancer. Scientific Reports. 9(1). 386–386. 46 indexed citations
3.
Richardsen, Elin, Sigve Andersen, Mehrdad Rakaee, et al.. (2018). Progesterone Receptors in Prostate Cancer: Progesterone receptor B is the isoform associated with disease progression. Scientific Reports. 8(1). 11358–11358. 32 indexed citations
4.
Nordby, Yngve, Elin Richardsen, Mehrdad Rakaee, et al.. (2017). High expression of PDGFR-β in prostate cancer stroma is independently associated with clinical and biochemical prostate cancer recurrence. Scientific Reports. 7(1). 43378–43378. 57 indexed citations
5.
Richardsen, Elin, Sigve Andersen, Samer Al‐Saad, et al.. (2017). Evaluation of the proliferation marker Ki-67 in a large prostatectomy cohort. PLoS ONE. 12(11). e0186852–e0186852. 39 indexed citations
6.
Nordby, Yngve, Elin Richardsen, Nora Ness, et al.. (2017). High miR-205 expression in normal epithelium is associated with biochemical failure - an argument for epithelial crosstalk in prostate cancer?. Scientific Reports. 7(1). 16308–16308. 15 indexed citations
7.
Ness, Nora, Sigve Andersen, Mehrdad Rakaee, et al.. (2017). The prognostic role of immune checkpoint markers programmed cell death protein 1 (PD-1) and programmed death ligand 1 (PD-L1) in a large, multicenter prostate cancer cohort. Oncotarget. 8(16). 26789–26801. 60 indexed citations
8.
Paulsen, Erna‐Elise, Thomas K. Kilvær, Mehrdad Rakaee, et al.. (2016). Assessing PDL-1 and PD-1 in Non–Small Cell Lung Cancer: A Novel Immunoscore Approach. Clinical Lung Cancer. 18(2). 220–233.e8. 72 indexed citations
9.
Andersen, Sigve, Nora Ness, Yngve Nordby, et al.. (2016). Estrogen receptors α and β and aromatase as independent predictors for prostate cancer outcome. Scientific Reports. 6(1). 33114–33114. 32 indexed citations
10.
Andersen, Sigve, Elin Richardsen, Tom Dønnem, et al.. (2016). Fibroblast miR-210 overexpression is independently associated with clinical failure in Prostate Cancer – a multicenter (in situ hybridization) study. Scientific Reports. 6(1). 36573–36573. 14 indexed citations
11.
Richardsen, Elin, Nora Ness, Samer Al‐Saad, et al.. (2015). The Prognostic Significance of CXCL16 and Its Receptor C-X-C Chemokine Receptor 6 in Prostate Cancer. American Journal Of Pathology. 185(10). 2722–2730. 31 indexed citations
12.
Andersen, Sigve, Tom Dønnem, Yngve Nordby, et al.. (2015). Organized metabolic crime in prostate cancer: The coexpression of MCT1 in tumor and MCT4 in stroma is an independent prognosticator for biochemical failure. Urologic Oncology Seminars and Original Investigations. 33(8). 338.e9–338.e17. 24 indexed citations
13.
Nordby, Yngve, Sigve Andersen, Elin Richardsen, et al.. (2015). Stromal expression of VEGF‐A and VEGFR‐2 in prostate tissue is associated with biochemical and clinical recurrence after radical prostatectomy. The Prostate. 75(15). 1682–1693. 28 indexed citations
14.
Ness, Nora, Sigve Andersen, Tom Dønnem, et al.. (2014). Stromal Expression of MiR-21 Predicts Biochemical Failure in Prostate Cancer Patients with Gleason Score 6. PLoS ONE. 9(11). e113039–e113039. 35 indexed citations
15.
Ness, Nora, Sigve Andersen, Andrej Valkov, et al.. (2014). Infiltration of CD8+ lymphocytes is an independent prognostic factor of biochemical failure-free survival in prostate cancer. The Prostate. 74(14). 1452–1461. 91 indexed citations
16.
Andersen, Sigve, Elin Richardsen, Yngve Nordby, et al.. (2014). Disease-specific outcomes of Radical Prostatectomies in Northern Norway; a case for the impact of perineural infiltration and postoperative PSA-doubling time. BMC Urology. 14(1). 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026